# Odyssey Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/odyssey-therapeutics

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.odysseytx.com
- Total disclosed funding: $571M
- Latest round: Series D (Jun 16, 2025)
- Investors on record: 28

## About

Based in Massachusetts, US, and founded in 2021 by Eicke Latz, Kim Lewis, Felix Meissner, and Florian Schmidt, Odyssey Therapeutics Inc. develops anti-inflammation immunotherapies to treat inflammatory diseases and cancer. As of February 2024, Gary D. Glick is the CEO of the company. In September 2025, Odyssey Therapeutics raised USD 213 million in series D funding from new investors Affinity Asset Advisors, Dimension Capital Management, Jeito Capital, Lightspeed Venture Partners, TPG, and Wedbush Securities. Other unspecified investors also participated in the round.

Odyssey Therapeutics Inc. develops novel therapeutics for patients with autoimmune diseases using modern machine-learning techniques. Its offerings include immunomodulators, oncology medicines, and many others.

## Funding rounds

- Series D, Jun 16, 2025, $214M — Lightspeed Venture Partners, TPG, Dimension Capital Management, Wedbush Securities, Jeito Capital, Affinity Asset Advisors
- Series C, Oct 25, 2023, $97M — OrbiMed Advisors, T Rowe Price, General Catalyst Partners, Colt Ventures, HBM Partners, SR One, Alexandria Venture Investments, Fidelity Investments, KB Investment, Leerink Partners, Foresite Capital, Walleye Capital, Creacion Ventures, Catalio Capital Management, AB Magnitude Ventures Group, Woodline Partners, BlackMars Capital, Ascenta Capital, Global BioAccess Fund
- Series B, May 13, 2022, $168M — OrbiMed Advisors, T Rowe Price, General Catalyst Partners, Colt Ventures, HBM Partners, SR One, Alexandria Venture Investments, Fidelity Investments, Silicon Valley Bank, GreatPoint Ventures, Foresite Capital, Walleye Capital, Logos Capital, Creacion Ventures, Catalio Capital Management, Woodline Partners
- Series A, Aug 30, 2021, $92M — OrbiMed Advisors, Colt Ventures, HBM Partners, SR One, Foresite Capital, Logos Capital, Creacion Ventures, Woodline Partners

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A, Series B, Series C
- Colt Ventures (https://capitalatlas.ai/funds/colt-ventures) — Series A, Series B, Series C
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series A, Series B, Series C
- SR One (https://capitalatlas.ai/funds/sr-one) — Series A, Series B, Series C
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series A, Series B, Series C
- Logos Capital (https://capitalatlas.ai/funds/logos-capital) — Series A, Series B
- Creacion Ventures (https://capitalatlas.ai/funds/creacion-ventures) — Series A, Series B, Series C
- Woodline Partners — Series A, Series B, Series C
- T Rowe Price (https://capitalatlas.ai/funds/t-rowe-price) — Series B, Series C
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series B, Series C
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B, Series C
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series B, Series C
- Silicon Valley Bank — Series B
- GreatPoint Ventures (https://capitalatlas.ai/funds/greatpoint-ventures) — Series B
- Walleye Capital — Series B, Series C
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series B, Series C
- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series C
- Leerink Partners — Series C
- AB Magnitude Ventures Group (https://capitalatlas.ai/funds/ab-magnitude-ventures-group) — Series C
- BlackMars Capital (https://capitalatlas.ai/funds/blackmars-capital) — Series C
- Ascenta Capital (https://capitalatlas.ai/funds/ascenta-capital) — Series C
- Global BioAccess Fund (https://capitalatlas.ai/funds/global-bioaccess-fund) — Series C
- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series D
- TPG (https://capitalatlas.ai/funds/tpg) — Series D
- Dimension Capital Management (https://capitalatlas.ai/funds/dimension-capital-management) — Series D
- Wedbush Securities — Series D
- Jeito Capital (https://capitalatlas.ai/funds/jeito-capital) — Series D
- Affinity Asset Advisors (https://capitalatlas.ai/funds/affinity-asset-advisors) — Series D